Ustekinumab Exposure in Pregnant Women From Inflammatory Bowel Disease Clinical Trials: Pregnancy Outcomes Through Up To 5 Years in Crohn’s Disease and 2 Years in Ulcerative Colitis

BACKGROUND: While no adverse developmental outcomes were observed in preclinical animal studies, limited data exist regarding effects of ustekinumab on human pregnancies. Previously, no data have been reported for women treated with ustekinumab in inflammatory bowel disease (IBD) clinical trials and...

Descripción completa

Detalles Bibliográficos
Autores principales: Abraham, Bincy P, Ott, Elyssa, Busse, Christopher, Murphy, Conor, Miller, Lindsay, Baumgart, Daniel C, Scherl, Ellen, Gasink, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Observations and Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802371/
https://www.ncbi.nlm.nih.gov/pubmed/36777422
http://dx.doi.org/10.1093/crocol/otac025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802371/
https://www.ncbi.nlm.nih.gov/pubmed/36777422
http://dx.doi.org/10.1093/crocol/otac025

Ejemplares similares